Oncology Total Assets from 2010 to 2024

TOIIW Stock

USD 0.01 0.00 0.00%

Oncology Institute Total Assets yearly trend continues to be fairly stable with very little volatility. Total Assets will likely drop to about 176.4 M in 2024. Total Assets is the total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets. View All Fundamentals

Total Assets

First Reported

2010-12-31

Previous Quarter

209.2 M

Current Value

176.4 M

Quarterly Volatility

72.1 M

Credit Downgrade

Yuan Drop

Covid

Check Oncology Institute financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Oncology Institute's main balance sheet or income statement drivers, such as Depreciation And Amortization of 3.8 M, Interest Expense of 7.1 M or Selling General Administrative of 67.6 M, as well as many indicators such as Price To Sales Ratio of 0.44, Dividend Yield of 0.0235 or PTB Ratio of 2.51. Oncology financial statements analysis is a perfect complement when working with Oncology Institute Valuation or Volatility modules.

Check out the analysis of Oncology Institute Correlation against competitors.

For more information on how to buy Oncology Stock please use our How to Invest in Oncology Institute guide.

Latest Oncology Institute's Total Assets Growth Pattern

Below is the plot of the Total Assets of The Oncology Institute over the last few years. Total assets refers to the total amount of Oncology Institute assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in The Oncology Institute books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. It is the total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets. Oncology Institute's Total Assets historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Oncology Institute's overall financial position and show how it may be relating to other accounts over time.

View

Last Reported 209.24 M

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Total Assets

Timeline

Oncology Total Assets Regression Statistics

	Arithmetic Mean	100,912,277
	Geometric Mean	83,956,865
	Coefficient Of Variation	71.47
	Mean Deviation	59,885,213
	Median	59,520,738
	Standard Deviation	72,124,950
	Sample Variance	5202T
	Range	204.2M
	R-Value	0.74
	Mean Square Error	2553T
	R-Squared	0.54
	Significance	0
	Slope	11,898,249
	Total Sum of Squares	72828.1T

Oncology Total Assets History

	2024	176.4 M
	2023	209.2 M
	2022	263.7 M
	2021	203.4 M
	2020	65.7 M

Other Fundumenentals of The Oncology Institute

Intangibles To Total Assets

Oncology Institute Total Assets component correlations

	Total Assets	Total Stockholder Equity	Net Debt	Retained Earnings	Accounts Payable	Net Receivables	Good Will	Total Liab	Net Invested Capital	Total Current Assets	Capital Stock	Net Working Capital	Intangible Assets	Common Stock	Current Deferred Revenue	Long Term Debt	Short Long Term Debt	Short Term Debt
Total Assets		0.9	0.4	-0.78	0.65	0.91	0.45	0.97	0.98	0.97	-0.91	0.96	-0.85	0.88	-0.94	0.98	-0.97	-0.32
Total Stockholder Equity	0.9		0.18	-0.5	0.43	0.68	0.75	0.78	0.89	0.84	-0.85	0.86	-0.69	0.68	-0.8	0.84	-0.85	-0.5
Net Debt	0.4	0.18		-0.55	0.0	0.69	-0.41	0.49	0.47	0.25	-0.33	0.21	-0.46	0.35	-0.34	0.34	-0.37	0.69
Retained Earnings	-0.78	-0.5	-0.55		-0.83	-0.85	0.06	-0.87	-0.72	-0.82	0.74	-0.79	0.93	-0.88	0.89	-0.84	0.87	0.1
Accounts Payable	0.65	0.43	0.0	-0.83		0.55	0.19	0.71	0.52	0.8	-0.58	0.76	-0.8	0.86	-0.8	0.75	-0.76	-0.54
Net Receivables	0.91	0.68	0.69	-0.85	0.55		0.08	0.96	0.93	0.85	-0.81	0.83	-0.8	0.84	-0.85	0.9	-0.88	0.07
Good Will	0.45	0.75	-0.41	0.06	0.19	0.08		0.25	0.4	0.42	-0.35	0.45	-0.25	0.3	-0.32	0.37	-0.37	-0.76
Total Liab	0.97	0.78	0.49	-0.87	0.71	0.96	0.25		0.95	0.96	-0.87	0.94	-0.87	0.92	-0.94	0.98	-0.96	-0.2
Net Invested Capital	0.98	0.89	0.47	-0.72	0.52	0.93	0.4	0.95		0.92	-0.92	0.93	-0.77	0.79	-0.9	0.95	-0.93	-0.21
Total Current Assets	0.97	0.84	0.25	-0.82	0.8	0.85	0.42	0.96	0.92		-0.91	1.0	-0.86	0.9	-0.98	0.99	-0.98	-0.46
Capital Stock	-0.91	-0.85	-0.33	0.74	-0.58	-0.81	-0.35	-0.87	-0.92	-0.91		-0.94	0.77	-0.69	0.94	-0.94	0.94	0.36
Net Working Capital	0.96	0.86	0.21	-0.79	0.76	0.83	0.45	0.94	0.93	1.0	-0.94		-0.82	0.86	-0.97	0.99	-0.98	-0.48
Intangible Assets	-0.85	-0.69	-0.46	0.93	-0.8	-0.8	-0.25	-0.87	-0.77	-0.86	0.77	-0.82		-0.92	0.92	-0.87	0.91	0.29
Common Stock	0.88	0.68	0.35	-0.88	0.86	0.84	0.3	0.92	0.79	0.9	-0.69	0.86	-0.92		-0.88	0.89	-0.89	-0.31
Current Deferred Revenue	-0.94	-0.8	-0.34	0.89	-0.8	-0.85	-0.32	-0.94	-0.9	-0.98	0.94	-0.97	0.92	-0.88		-0.98	0.99	0.4
Long Term Debt	0.98	0.84	0.34	-0.84	0.75	0.9	0.37	0.98	0.95	0.99	-0.94	0.99	-0.87	0.89	-0.98		-0.99	-0.37
Short Long Term Debt	-0.97	-0.85	-0.37	0.87	-0.76	-0.88	-0.37	-0.96	-0.93	-0.98	0.94	-0.98	0.91	-0.89	0.99	-0.99		0.38
Short Term Debt	-0.32	-0.5	0.69	0.1	-0.54	0.07	-0.76	-0.2	-0.21	-0.46	0.36	-0.48	0.29	-0.31	0.4	-0.37	0.38

Click cells to compare fundamentals

About Oncology Institute Financial Statements

Oncology Institute investors use historical fundamental indicators, such as Oncology Institute's Total Assets, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Oncology Institute. Please read more on our technical analysis and fundamental analysis pages.

	Last Reported	Projected for Next Year
Total Assets	209.2 M	176.4 M
Intangibles To Total Assets	0.12	0.11

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

C	Citigroup
GM	General Motors
F	Ford Motor

Additional Tools for Oncology Stock Analysis

When running Oncology Institute's price analysis, check to measure Oncology Institute's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Oncology Institute is operating at the current time. Most of Oncology Institute's value examination focuses on studying past and present price action to predict the probability of Oncology Institute's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Oncology Institute's price. Additionally, you may evaluate how the addition of Oncology Institute to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC